메뉴 건너뛰기




Volumn 109, Issue 7, 2015, Pages 803-812

MicroRNA as tools and therapeutics in lung cancer

Author keywords

Cancer; Lung; microRNA

Indexed keywords

MICRORNA; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR MARKER;

EID: 84930756777     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.02.006     Document Type: Review
Times cited : (100)

References (115)
  • 1
    • 79961108629 scopus 로고    scopus 로고
    • Reduced lung-cancer mortality with low-dose computed tomographic screening
    • National Lung Screening Trial Research Team D.R. Aberle, and A.M. Adams Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409 10.1056/NEJMoa1102873
    • (2011) N Engl J Med , vol.365 , pp. 395-409
    • Aberle, D.R.1    Adams, A.M.2
  • 2
    • 84907591805 scopus 로고    scopus 로고
    • Lung cancer screening beyond low-dose computed tomography: The role of novel biomarkers
    • N. Hasan, R. Kumar, and M.S. Kavuru Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers Lung 2014 639 648 10.1007/s00408-014-9636-z
    • (2014) Lung , pp. 639-648
    • Hasan, N.1    Kumar, R.2    Kavuru, M.S.3
  • 3
    • 84886290631 scopus 로고    scopus 로고
    • The impact of genomic changes on treatment of lung cancer
    • S. Cardarella, and B.E. Johnson The impact of genomic changes on treatment of lung cancer Am J Respir Crit Care Med 188 2013 770 775 10.1164/rccm.201305-0843PP
    • (2013) Am J Respir Crit Care Med , vol.188 , pp. 770-775
    • Cardarella, S.1    Johnson, B.E.2
  • 4
    • 0027751663 scopus 로고
    • The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
    • 0092-8674(93)90529-Y [pii]
    • R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854 doi:0092-8674(93)90529-Y [pii]
    • (1993) Cell , vol.75 , pp. 843-854
    • Lee, R.C.1    Feinbaum, R.L.2    Ambros, V.3
  • 5
    • 0034597777 scopus 로고    scopus 로고
    • Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA
    • A.E. Pasquinelli, B.J. Reinhart, and F. Slack Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA Nature 408 2000 86 89 10.1038/35040556
    • (2000) Nature , vol.408 , pp. 86-89
    • Pasquinelli, A.E.1    Reinhart, B.J.2    Slack, F.3
  • 6
    • 20444460289 scopus 로고    scopus 로고
    • MicroRNA expression profiles classify human cancers
    • nature03702 [pii]
    • J. Lu, G. Getz, and E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838 doi:nature03702 [pii]
    • (2005) Nature , vol.435 , pp. 834-838
    • Lu, J.1    Getz, G.2    Miska, E.A.3
  • 7
    • 8144225486 scopus 로고    scopus 로고
    • MicroRNA genes are transcribed by RNA polymerase II
    • Y. Lee, M. Kim, and J. Han MicroRNA genes are transcribed by RNA polymerase II EMBO J 23 2004 4051 4060 10.1038/sj.emboj.7600385
    • (2004) EMBO J , vol.23 , pp. 4051-4060
    • Lee, Y.1    Kim, M.2    Han, J.3
  • 8
    • 10644234841 scopus 로고    scopus 로고
    • The drosha-DGCR8 complex in primary microRNA processing
    • gad.1262504 [pii]
    • J. Han, Y. Lee, K.H. Yeom, Y.K. Kim, H. Jin, and V.N. Kim The drosha-DGCR8 complex in primary microRNA processing Genes Dev 18 2004 3016 3027 doi:gad.1262504 [pii]
    • (2004) Genes Dev , vol.18 , pp. 3016-3027
    • Han, J.1    Lee, Y.2    Yeom, K.H.3    Kim, Y.K.4    Jin, H.5    Kim, V.N.6
  • 9
    • 9344235449 scopus 로고    scopus 로고
    • Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs
    • rna.7135204 [pii]
    • X. Cai, C.H. Hagedorn, and B.R. Cullen Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs RNA 10 2004 1957 1966 doi:rna.7135204 [pii]
    • (2004) RNA , vol.10 , pp. 1957-1966
    • Cai, X.1    Hagedorn, C.H.2    Cullen, B.R.3
  • 10
    • 67749129007 scopus 로고    scopus 로고
    • DICER1 mutations in familial pleuropulmonary blastoma
    • D.A. Hill, J. Ivanovich, and J.R. Priest DICER1 mutations in familial pleuropulmonary blastoma Science 325 2009 965 10.1126/science.1174334
    • (2009) Science , vol.325 , pp. 965
    • Hill, D.A.1    Ivanovich, J.2    Priest, J.R.3
  • 11
    • 20144373433 scopus 로고    scopus 로고
    • Reduced expression of dicer associated with poor prognosis in lung cancer patients
    • Y. Karube, H. Tanaka, and H. Osada Reduced expression of dicer associated with poor prognosis in lung cancer patients Cancer Sci 96 2005 111 115 10.1111/j.1349-7006.2005.00015.x
    • (2005) Cancer Sci , vol.96 , pp. 111-115
    • Karube, Y.1    Tanaka, H.2    Osada, H.3
  • 12
    • 33644819964 scopus 로고    scopus 로고
    • Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
    • S1535-6108(06)00033-X[pii]
    • N. Yanaihara, N. Caplen, and E. Bowman Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 2006 189 198 doi:S1535-6108(06)00033-X[pii]
    • (2006) Cancer Cell , vol.9 , pp. 189-198
    • Yanaihara, N.1    Caplen, N.2    Bowman, E.3
  • 13
    • 33144490646 scopus 로고    scopus 로고
    • A microRNA expression signature of human solid tumors defines cancer gene targets
    • 0510565103 [pii]
    • S. Volinia, G.A. Calin, and C.G. Liu A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 2006 2257 2261 doi:0510565103 [pii]
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 2257-2261
    • Volinia, S.1    Calin, G.A.2    Liu, C.G.3
  • 14
    • 48749122914 scopus 로고    scopus 로고
    • Circulating microRNAs as stable blood-based markers for cancer detection
    • P.S. Mitchell, R.K. Parkin, and E.M. Kroh Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518 10.1073/pnas.0804549105
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 10513-10518
    • Mitchell, P.S.1    Parkin, R.K.2    Kroh, E.M.3
  • 16
    • 84865063456 scopus 로고    scopus 로고
    • Classification of the four main types of lung cancer using a microRNA-based diagnostic assay
    • S. Gilad, G. Lithwick-Yanai, and I. Barshack Classification of the four main types of lung cancer using a microRNA-based diagnostic assay J Mol Diagn 14 2012 510 517 10.1016/j.jmoldx.2012.03.004
    • (2012) J Mol Diagn , vol.14 , pp. 510-517
    • Gilad, S.1    Lithwick-Yanai, G.2    Barshack, I.3
  • 17
    • 2542626605 scopus 로고    scopus 로고
    • Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
    • J. Takamizawa, H. Konishi, and K. Yanagisawa Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res 64 2004 3753 3756 10.1158/0008-5472.CAN-04-0637
    • (2004) Cancer Res , vol.64 , pp. 3753-3756
    • Takamizawa, J.1    Konishi, H.2    Yanagisawa, K.3
  • 18
    • 74549118209 scopus 로고    scopus 로고
    • Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach
    • J.A. Bishop, H. Benjamin, H. Cholakh, A. Chajut, D.P. Clark, and W.H. Westra Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach Clin Cancer Res 16 2010 610 619 10.1158/1078-0432.CCR-09-2638
    • (2010) Clin Cancer Res , vol.16 , pp. 610-619
    • Bishop, J.A.1    Benjamin, H.2    Cholakh, H.3    Chajut, A.4    Clark, D.P.5    Westra, W.H.6
  • 19
    • 84879983640 scopus 로고    scopus 로고
    • Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma
    • J. Hamamoto, K. Soejima, and S. Yoda Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma Mol Med Rep 8 2013 456 462 10.3892/mmr.2013.1517
    • (2013) Mol Med Rep , vol.8 , pp. 456-462
    • Hamamoto, J.1    Soejima, K.2    Yoda, S.3
  • 20
    • 65349166324 scopus 로고    scopus 로고
    • Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma
    • D. Lebanony, H. Benjamin, and S. Gilad Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma J Clin Oncol 27 2009 2030 2037 10.1200/JCO.2008.19.4134
    • (2009) J Clin Oncol , vol.27 , pp. 2030-2037
    • Lebanony, D.1    Benjamin, H.2    Gilad, S.3
  • 21
    • 77953139378 scopus 로고    scopus 로고
    • Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin
    • S. Rosenwald, S. Gilad, and S. Benjamin Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin Mod Pathol 23 2010 814 823 10.1038/modpathol.2010.57
    • (2010) Mod Pathol , vol.23 , pp. 814-823
    • Rosenwald, S.1    Gilad, S.2    Benjamin, S.3
  • 22
    • 77954316346 scopus 로고    scopus 로고
    • MicroRNA expression differentiates between primary lung tumors and metastases to the lung
    • I. Barshack, G. Lithwick-Yanai, and A. Afek MicroRNA expression differentiates between primary lung tumors and metastases to the lung Pathol Res Pract 206 2010 578 584 10.1016/j.prp.2010.03.005
    • (2010) Pathol Res Pract , vol.206 , pp. 578-584
    • Barshack, I.1    Lithwick-Yanai, G.2    Afek, A.3
  • 23
    • 84902986190 scopus 로고    scopus 로고
    • MiR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung
    • 34/5/2297 [pii]
    • J. Kim, N.J. Lim, S.G. Jang, H.K. Kim, and G.K. Lee miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung Anticancer Res 34 2014 2297 2302 doi:34/5/2297 [pii]
    • (2014) Anticancer Res , vol.34 , pp. 2297-2302
    • Kim, J.1    Lim, N.J.2    Jang, S.G.3    Kim, H.K.4    Lee, G.K.5
  • 24
    • 84897015133 scopus 로고    scopus 로고
    • Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: A correlative MILD trial study
    • G. Sozzi, M. Boeri, and M. Rossi Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study J Clin Oncol 32 2014 768 773 10.1200/JCO.2013.50.4357
    • (2014) J Clin Oncol , vol.32 , pp. 768-773
    • Sozzi, G.1    Boeri, M.2    Rossi, M.3
  • 25
    • 84859295557 scopus 로고    scopus 로고
    • Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial
    • U. Pastorino, M. Rossi, and V. Rosato Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial Eur J Cancer Prev 21 2012 308 315 10.1097/CEJ.0b013e328351e1b6
    • (2012) Eur J Cancer Prev , vol.21 , pp. 308-315
    • Pastorino, U.1    Rossi, M.2    Rosato, V.3
  • 26
    • 84977478146 scopus 로고    scopus 로고
    • MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
    • M. Boeri, C. Verri, and D. Conte MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer Proc Natl Acad Sci U S A 108 2011 3713 3718 10.1073/pnas.1100048108
    • (2011) Proc Natl Acad Sci U S A , vol.108 , pp. 3713-3718
    • Boeri, M.1    Verri, C.2    Conte, D.3
  • 27
    • 80052027132 scopus 로고    scopus 로고
    • Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers
    • 374-2407-11-374
    • J. Shen, Z. Liu, and N.W. Todd Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers BMC Cancer 11 2011 10.1186/1471-2407-11-374 374-2407-11-374
    • (2011) BMC Cancer , vol.11
    • Shen, J.1    Liu, Z.2    Todd, N.W.3
  • 28
    • 20544455590 scopus 로고    scopus 로고
    • Vinorelbine plus cisplatin vs. Observation in resected non-small-cell lung cancer
    • 352/25/2589 [pii]
    • T. Winton, R. Livingston, and D. Johnson Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597 doi:352/25/2589 [pii]
    • (2005) N Engl J Med , vol.352 , pp. 2589-2597
    • Winton, T.1    Livingston, R.2    Johnson, D.3
  • 29
    • 70349304187 scopus 로고    scopus 로고
    • Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: An analysis of the national cancer institute of canada clinical trials group JBR.10 trial
    • R.W. Jang, A. Le Maitre, and K. Ding Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the national cancer institute of canada clinical trials group JBR.10 trial J Clin Oncol 27 2009 4268 4273 10.1200/JCO.2008.20.5815
    • (2009) J Clin Oncol , vol.27 , pp. 4268-4273
    • Jang, R.W.1    Le Maitre, A.2    Ding, K.3
  • 30
    • 2342624080 scopus 로고    scopus 로고
    • EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
    • J.G. Paez, P.A. Janne, and J.C. Lee EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500 10.1126/science.1099314
    • (2004) Science , vol.304 , pp. 1497-1500
    • Paez, J.G.1    Janne, P.A.2    Lee, J.C.3
  • 31
    • 45149084723 scopus 로고    scopus 로고
    • First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations
    • L.V. Sequist, R.G. Martins, and D. Spigel First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations J Clin Oncol 26 2008 2442 2449 10.1200/JCO.2007.14.8494
    • (2008) J Clin Oncol , vol.26 , pp. 2442-2449
    • Sequist, L.V.1    Martins, R.G.2    Spigel, D.3
  • 32
    • 79959443241 scopus 로고    scopus 로고
    • MicroRNA expression and clinical outcome of small cell lung cancer
    • J.H. Lee, J. Voortman, and A.M. Dingemans MicroRNA expression and clinical outcome of small cell lung cancer PLoS One 6 2011 e21300 10.1371/journal.pone.0021300
    • (2011) PLoS One , vol.6 , pp. e21300
    • Lee, J.H.1    Voortman, J.2    Dingemans, A.M.3
  • 33
    • 20044395613 scopus 로고    scopus 로고
    • RAS is regulated by the let-7 microRNA family
    • S0092-8674(05)00088-7[pii]
    • S.M. Johnson, H. Grosshans, and J. Shingara RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647 doi:S0092-8674(05)00088-7[pii]
    • (2005) Cell , vol.120 , pp. 635-647
    • Johnson, S.M.1    Grosshans, H.2    Shingara, J.3
  • 34
    • 34247565615 scopus 로고    scopus 로고
    • The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
    • gad.1540407 [pii]
    • Y.S. Lee, and A. Dutta The tumor suppressor microRNA let-7 represses the HMGA2 oncogene Genes Dev 21 2007 1025 1030 doi:gad.1540407 [pii]
    • (2007) Genes Dev , vol.21 , pp. 1025-1030
    • Lee, Y.S.1    Dutta, A.2
  • 35
    • 84857503465 scopus 로고    scopus 로고
    • Let-7 modulates acquired resistance of ovarian cancer to taxanes via IMP-1-mediated stabilization of multidrug resistance 1
    • B. Boyerinas, S.M. Park, and A.E. Murmann Let-7 modulates acquired resistance of ovarian cancer to taxanes via IMP-1-mediated stabilization of multidrug resistance 1 Int J Cancer 130 2012 1787 1797 10.1002/ijc.26190
    • (2012) Int J Cancer , vol.130 , pp. 1787-1797
    • Boyerinas, B.1    Park, S.M.2    Murmann, A.E.3
  • 36
    • 79960799901 scopus 로고    scopus 로고
    • Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer
    • C.J. Chang, C.C. Hsu, and C.H. Chang Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer Oncol Rep 26 2011 1003 1010 10.3892/or.2011.1360
    • (2011) Oncol Rep , vol.26 , pp. 1003-1010
    • Chang, C.J.1    Hsu, C.C.2    Chang, C.H.3
  • 37
    • 37049019490 scopus 로고    scopus 로고
    • MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy
    • 67/23/11111 [pii]
    • J.B. Weidhaas, I. Babar, and S.M. Nallur MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy Cancer Res 67 2007 11111 11116 doi:67/23/11111 [pii]
    • (2007) Cancer Res , vol.67 , pp. 11111-11116
    • Weidhaas, J.B.1    Babar, I.2    Nallur, S.M.3
  • 38
    • 69249096109 scopus 로고    scopus 로고
    • Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
    • Y. Li, T.G. VandenBoom 2nd, and D. Kong Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells Cancer Res 69 2009 6704 6712 10.1158/0008-5472.CAN-09-1298
    • (2009) Cancer Res , vol.69 , pp. 6704-6712
    • Li, Y.1    Vandenboom, T.G.2    Kong, D.3
  • 39
    • 44849091213 scopus 로고    scopus 로고
    • EGFR regulation by microRNA in lung cancer: Correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
    • G.J. Weiss, L.T. Bemis, and E. Nakajima EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines Ann Oncol 19 2008 1053 1059 10.1093/annonc/mdn006
    • (2008) Ann Oncol , vol.19 , pp. 1053-1059
    • Weiss, G.J.1    Bemis, L.T.2    Nakajima, E.3
  • 40
    • 84905559842 scopus 로고    scopus 로고
    • MicroRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C
    • J. Hu, Y. Cheng, and Y. Li microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C Eur J Cancer 50 2014 2336 2350 10.1016/j.ejca.2014.06.005
    • (2014) Eur J Cancer , vol.50 , pp. 2336-2350
    • Hu, J.1    Cheng, Y.2    Li, Y.3
  • 41
    • 84863361375 scopus 로고    scopus 로고
    • MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1
    • Z.M. Shi, J. Wang, and Z. Yan MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1 PLoS One 7 2012 e32709 10.1371/journal.pone.0032709
    • (2012) PLoS One , vol.7 , pp. e32709
    • Shi, Z.M.1    Wang, J.2    Yan, Z.3
  • 42
    • 84860289964 scopus 로고    scopus 로고
    • Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer
    • CTMC-EPUB-20120214-010 [pii]
    • L.W. Chan, F.F. Wang, and W.C. Cho Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer Curr Top Med Chem 12 2012 920 926 doi:CTMC-EPUB-20120214-010 [pii]
    • (2012) Curr Top Med Chem , vol.12 , pp. 920-926
    • Chan, L.W.1    Wang, F.F.2    Cho, W.C.3
  • 43
    • 84866541922 scopus 로고    scopus 로고
    • MicroRNA-29b is involved in the src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma
    • S.I. Rothschild, M.P. Tschan, and E.A. Federzoni MicroRNA-29b is involved in the src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma Oncogene 31 2012 4221 4232 10.1038/onc.2011.578
    • (2012) Oncogene , vol.31 , pp. 4221-4232
    • Rothschild, S.I.1    Tschan, M.P.2    Federzoni, E.A.3
  • 44
    • 84938934841 scopus 로고    scopus 로고
    • C-myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT
    • D.W. Wu, N.Y. Hsu, and Y.C. Wang C-myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT Oncogene 0 2014 10.1038/onc.2014.152
    • (2014) Oncogene
    • Wu, D.W.1    Hsu, N.Y.2    Wang, Y.C.3
  • 45
    • 35649020283 scopus 로고    scopus 로고
    • MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B
    • 0707628104 [pii]
    • M. Fabbri, R. Garzon, and A. Cimmino MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc Natl Acad Sci U S A 104 2007 15805 15810 doi:0707628104 [pii]
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 15805-15810
    • Fabbri, M.1    Garzon, R.2    Cimmino, A.3
  • 46
    • 80052399265 scopus 로고    scopus 로고
    • MicroRNA-449 in cell fate determination
    • 17181 [pii]
    • M. Lize, A. Klimke, and M. Dobbelstein MicroRNA-449 in cell fate determination Cell Cycle 10 2011 2874 2882 doi:17181 [pii]
    • (2011) Cell Cycle , vol.10 , pp. 2874-2882
    • Lize, M.1    Klimke, A.2    Dobbelstein, M.3
  • 47
    • 79955913660 scopus 로고    scopus 로고
    • MiR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and rb-dependent manner
    • 55-4598-10-55
    • N. Bandi, and E. Vassella miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and rb-dependent manner Mol Cancer 10 2011 10.1186/1476-4598-10-55 55-4598-10-55
    • (2011) Mol Cancer , vol.10
    • Bandi, N.1    Vassella, E.2
  • 48
    • 84896897599 scopus 로고    scopus 로고
    • A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
    • N. Okada, C.P. Lin, and M.C. Ribeiro A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression Genes Dev 28 2014 438 450 10.1101/gad.233585.113
    • (2014) Genes Dev , vol.28 , pp. 438-450
    • Okada, N.1    Lin, C.P.2    Ribeiro, M.C.3
  • 49
    • 84856231030 scopus 로고    scopus 로고
    • MiRNA-34a is associated with docetaxel resistance in human breast cancer cells
    • L. Kastl, I. Brown, and A.C. Schofield miRNA-34a is associated with docetaxel resistance in human breast cancer cells Breast Cancer Res Treat 131 2012 445 454 10.1007/s10549-011-1424-3
    • (2012) Breast Cancer Res Treat , vol.131 , pp. 445-454
    • Kastl, L.1    Brown, I.2    Schofield, A.C.3
  • 50
    • 84883743256 scopus 로고    scopus 로고
    • TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.)
    • J. Zhao, P. Lammers, C.J. Torrance, and A.G. Bader TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.) Mol Ther 21 2013 1678 1686 10.1038/mt.2013.148
    • (2013) Mol Ther , vol.21 , pp. 1678-1686
    • Zhao, J.1    Lammers, P.2    Torrance, C.J.3    Bader, A.G.4
  • 51
    • 51349157982 scopus 로고    scopus 로고
    • The MYCN oncogene is a direct target of miR-34a
    • J.S. Wei, Y.K. Song, and S. Durinck The MYCN oncogene is a direct target of miR-34a Oncogene 27 2008 5204 5213 10.1038/onc.2008.154
    • (2008) Oncogene , vol.27 , pp. 5204-5213
    • Wei, J.S.1    Song, Y.K.2    Durinck, S.3
  • 52
    • 80052698948 scopus 로고    scopus 로고
    • Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells
    • K. Rai, N. Takigawa, and S. Ito Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells Mol Cancer Ther 10 2011 1720 1727 10.1158/1535-7163.MCT-11-0220
    • (2011) Mol Cancer Ther , vol.10 , pp. 1720-1727
    • Rai, K.1    Takigawa, N.2    Ito, S.3
  • 53
    • 80655149145 scopus 로고    scopus 로고
    • MicroRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling
    • K.M. Lee, E.J. Choi, and I.A. Kim microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling Radiother Oncol 101 2011 171 176 10.1016/j.radonc.2011.05.050
    • (2011) Radiother Oncol , vol.101 , pp. 171-176
    • Lee, K.M.1    Choi, E.J.2    Kim, I.A.3
  • 54
    • 84860261087 scopus 로고    scopus 로고
    • High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
    • X.G. Liu, W.Y. Zhu, and Y.Y. Huang High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer Med Oncol 29 2012 618 626 10.1007/s12032-011-9923-y
    • (2012) Med Oncol , vol.29 , pp. 618-626
    • Liu, X.G.1    Zhu, W.Y.2    Huang, Y.Y.3
  • 55
    • 84255191994 scopus 로고    scopus 로고
    • Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer
    • M.J. Schliekelman, D.L. Gibbons, and V.M. Faca Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer Cancer Res 71 2011 7670 7682 10.1158/0008-5472.CAN-11-0964
    • (2011) Cancer Res , vol.71 , pp. 7670-7682
    • Schliekelman, M.J.1    Gibbons, D.L.2    Faca, V.M.3
  • 56
    • 84910609183 scopus 로고    scopus 로고
    • MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1
    • C. Gao, F.H. Peng, and L.K. Peng MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1 Neoplasma 2014 680 689 10.4149/neo-2014-083
    • (2014) Neoplasma , pp. 680-689
    • Gao, C.1    Peng, F.H.2    Peng, L.K.3
  • 57
    • 84876557012 scopus 로고    scopus 로고
    • Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells
    • e62334
    • T.T. Manavalan, Y. Teng, L.M. Litchfield, P. Muluhngwi, N. Al-Rayyan, and C.M. Klinge Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells PLoS One 8 2013 10.1371/journal.pone.0062334 e62334
    • (2013) PLoS One , vol.8
    • Manavalan, T.T.1    Teng, Y.2    Litchfield, L.M.3    Muluhngwi, P.4    Al-Rayyan, N.5    Klinge, C.M.6
  • 58
    • 84905489718 scopus 로고    scopus 로고
    • Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer
    • M.A. Cortez, D. Valdecanas, and X. Zhang Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer Mol Ther 22 2014 1494 1503 10.1038/mt.2014.79
    • (2014) Mol Ther , vol.22 , pp. 1494-1503
    • Cortez, M.A.1    Valdecanas, D.2    Zhang, X.3
  • 59
    • 79959298372 scopus 로고    scopus 로고
    • Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer
    • 1944-446X201106407[pii]
    • J. Wei, W. Gao, and C.J. Zhu Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer Chin J Cancer 30 2011 407 414 doi:1944-446X201106407[pii]
    • (2011) Chin J Cancer , vol.30 , pp. 407-414
    • Wei, J.1    Gao, W.2    Zhu, C.J.3
  • 60
    • 84886822565 scopus 로고    scopus 로고
    • MicroRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation
    • 750-013-0750-1. Epub 2013 Nov 6
    • Y. Shen, D. Tang, and R. Yao microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation Med Oncol 30 2013 10.1007/s12032-013-0750-1 750-013-0750-1. Epub 2013 Nov 6
    • (2013) Med Oncol , vol.30
    • Shen, Y.1    Tang, D.2    Yao, R.3
  • 61
    • 84882726021 scopus 로고    scopus 로고
    • MicroRNA-21: A therapeutic target for reversing drug resistance in cancer
    • L. Hong, Y. Han, and Y. Zhang MicroRNA-21: a therapeutic target for reversing drug resistance in cancer Expert Opin Ther Targets 17 2013 1073 1080 10.1517/14728222.2013.819853
    • (2013) Expert Opin Ther Targets , vol.17 , pp. 1073-1080
    • Hong, L.1    Han, Y.2    Zhang, Y.3
  • 62
    • 84892888388 scopus 로고    scopus 로고
    • MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
    • B. Li, S. Ren, and X. Li MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer Lung Cancer 83 2014 146 153 10.1016/j.lungcan.2013.11.003
    • (2014) Lung Cancer , vol.83 , pp. 146-153
    • Li, B.1    Ren, S.2    Li, X.3
  • 63
    • 70949104622 scopus 로고    scopus 로고
    • MiR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation
    • M. Garofalo, G. Di Leva, and G. Romano miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation Cancer Cell 16 2009 498 509 10.1016/j.ccr.2009.10.014
    • (2009) Cancer Cell , vol.16 , pp. 498-509
    • Garofalo, M.1    Di Leva, G.2    Romano, G.3
  • 64
    • 84906283166 scopus 로고    scopus 로고
    • MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2
    • Z. Mei, Y. He, and J. Feng MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2 FEBS Lett 588 2014 3055 3061 10.1016/j.febslet.2014.06.020
    • (2014) FEBS Lett , vol.588 , pp. 3055-3061
    • Mei, Z.1    He, Y.2    Feng, J.3
  • 65
    • 79952195451 scopus 로고    scopus 로고
    • Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer
    • X.C. Wang, L.Q. Du, and L.L. Tian Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer Lung Cancer 72 2011 92 99 10.1016/j.lungcan.2010.07.014
    • (2011) Lung Cancer , vol.72 , pp. 92-99
    • Wang, X.C.1    Du, L.Q.2    Tian, L.L.3
  • 66
    • 84862877840 scopus 로고    scopus 로고
    • High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease
    • A. Ruzzo, F. Graziano, and B. Vincenzi High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease Oncologist 17 2012 823 829 10.1634/theoncologist.2012-0081
    • (2012) Oncologist , vol.17 , pp. 823-829
    • Ruzzo, A.1    Graziano, F.2    Vincenzi, B.3
  • 67
    • 84869195391 scopus 로고    scopus 로고
    • Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; Colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
    • 534-2407-12-534
    • J.B. Kjersem, T. Ikdahl, and T. Guren Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab BMC Cancer 12 2012 10.1186/1471-2407-12-534 534-2407-12-534
    • (2012) BMC Cancer , vol.12
    • Kjersem, J.B.1    Ikdahl, T.2    Guren, T.3
  • 68
    • 84880594419 scopus 로고    scopus 로고
    • Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features
    • A. Capodanno, L. Boldrini, and A. Proietti Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features Int J Oncol 43 2013 765 774 10.3892/ijo.2013.2003
    • (2013) Int J Oncol , vol.43 , pp. 765-774
    • Capodanno, A.1    Boldrini, L.2    Proietti, A.3
  • 69
    • 67650422613 scopus 로고    scopus 로고
    • MiR-15a and miR-16 are implicated in cell cycle regulation in a rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer
    • N. Bandi, S. Zbinden, and M. Gugger miR-15a and miR-16 are implicated in cell cycle regulation in a rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer Cancer Res 69 2009 5553 5559 10.1158/0008-5472.CAN-08-4277
    • (2009) Cancer Res , vol.69 , pp. 5553-5559
    • Bandi, N.1    Zbinden, S.2    Gugger, M.3
  • 70
    • 70849087385 scopus 로고    scopus 로고
    • MiR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
    • E. Gallardo, A. Navarro, and N. Vinolas miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer Carcinogenesis 30 2009 1903 1909 10.1093/carcin/bgp219
    • (2009) Carcinogenesis , vol.30 , pp. 1903-1909
    • Gallardo, E.1    Navarro, A.2    Vinolas, N.3
  • 71
    • 79952331586 scopus 로고    scopus 로고
    • DNA hypermethylation of microRNA-34b/c has prognostic value for stage non-small cell lung cancer
    • Z. Wang, Z. Chen, and Y. Gao DNA hypermethylation of microRNA-34b/c has prognostic value for stage non-small cell lung cancer Cancer Biol Ther 11 2011 490 496 10.4161/cbt.11.5.14550
    • (2011) Cancer Biol Ther , vol.11 , pp. 490-496
    • Wang, Z.1    Chen, Z.2    Gao, Y.3
  • 72
    • 79951938163 scopus 로고    scopus 로고
    • DNA methylation of tumor suppressor miRNA genes: A lesson from the miR-34 family
    • K.Y. Wong, L. Yu, and C.S. Chim DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family Epigenomics 3 2011 83 92 10.2217/epi.10.74
    • (2011) Epigenomics , vol.3 , pp. 83-92
    • Wong, K.Y.1    Yu, L.2    Chim, C.S.3
  • 73
    • 84855729906 scopus 로고    scopus 로고
    • A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition
    • N.H. Kim, H.S. Kim, and X.Y. Li A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition J Cell Biol 195 2011 417 433 10.1083/jcb.201103097
    • (2011) J Cell Biol , vol.195 , pp. 417-433
    • Kim, N.H.1    Kim, H.S.2    Li, X.Y.3
  • 74
    • 84861496878 scopus 로고    scopus 로고
    • Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines
    • 32/5/1603 [pii]
    • J. Balca-Silva, S. Sousa Neves, and A.C. Goncalves Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines Anticancer Res 32 2012 1603 1609 doi:32/5/1603 [pii]
    • (2012) Anticancer Res , vol.32 , pp. 1603-1609
    • Balca-Silva, J.1    Sousa Neves, S.2    Goncalves, A.C.3
  • 75
    • 57749110627 scopus 로고    scopus 로고
    • MicroRNAs impair MET-mediated invasive growth
    • C. Migliore, A. Petrelli, and E. Ghiso MicroRNAs impair MET-mediated invasive growth Cancer Res 68 2008 10128 10136 10.1158/0008-5472.CAN-08-2148
    • (2008) Cancer Res , vol.68 , pp. 10128-10136
    • Migliore, C.1    Petrelli, A.2    Ghiso, E.3
  • 76
    • 84903879534 scopus 로고    scopus 로고
    • MiR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma
    • R. Tejero, A. Navarro, and M. Campayo miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma PLoS One 9 2014 e101899 10.1371/journal.pone.0101899
    • (2014) PLoS One , vol.9 , pp. e101899
    • Tejero, R.1    Navarro, A.2    Campayo, M.3
  • 77
    • 84872674726 scopus 로고    scopus 로고
    • High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer
    • M. Yang, H. Shen, and C. Qiu High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer Eur J Cancer 49 2013 604 615 10.1016/j.ejca.2012.09.031
    • (2013) Eur J Cancer , vol.49 , pp. 604-615
    • Yang, M.1    Shen, H.2    Qiu, C.3
  • 78
    • 84885146774 scopus 로고    scopus 로고
    • Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients
    • M. Jiang, P. Zhang, and G. Hu Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients Mol Cell Biochem 383 2013 67 75 10.1007/s11010-013-1755-y
    • (2013) Mol Cell Biochem , vol.383 , pp. 67-75
    • Jiang, M.1    Zhang, P.2    Hu, G.3
  • 79
    • 84883743438 scopus 로고    scopus 로고
    • MiR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
    • M.T. van Jaarsveld, J. Helleman, and A.W. Boersma miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells Oncogene 32 2013 4284 4293 10.1038/onc.2012.433
    • (2013) Oncogene , vol.32 , pp. 4284-4293
    • Van Jaarsveld, M.T.1    Helleman, J.2    Boersma, A.W.3
  • 80
    • 79955499785 scopus 로고    scopus 로고
    • MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma
    • Y. Imanaka, S. Tsuchiya, F. Sato, Y. Shimada, K. Shimizu, and G. Tsujimoto MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma J Hum Genet 56 2011 270 276 10.1038/jhg.2011.1
    • (2011) J Hum Genet , vol.56 , pp. 270-276
    • Imanaka, Y.1    Tsuchiya, S.2    Sato, F.3    Shimada, Y.4    Shimizu, K.5    Tsujimoto, G.6
  • 81
    • 84855543629 scopus 로고    scopus 로고
    • EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
    • M. Garofalo, G. Romano, and G. Di Leva EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers Nat Med 18 2011 74 82 10.1038/nm.2577
    • (2011) Nat Med , vol.18 , pp. 74-82
    • Garofalo, M.1    Romano, G.2    Di Leva, G.3
  • 82
    • 33847763576 scopus 로고    scopus 로고
    • Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
    • 67/4/1424 [pii]
    • A. Lujambio, S. Ropero, and E. Ballestar Genetic unmasking of an epigenetically silenced microRNA in human cancer cells Cancer Res 67 2007 1424 1429 doi:67/4/1424 [pii]
    • (2007) Cancer Res , vol.67 , pp. 1424-1429
    • Lujambio, A.1    Ropero, S.2    Ballestar, E.3
  • 83
    • 16244400457 scopus 로고    scopus 로고
    • FDA drug approval summary: Azacitidine (5-azacytidine, vidaza) for injectable suspension
    • 10/3/176 [pii]
    • E. Kaminskas, A.T. Farrell, Y.C. Wang, R. Sridhara, and R. Pazdur FDA drug approval summary: Azacitidine (5-azacytidine, vidaza) for injectable suspension Oncologist 10 2005 176 182 doi:10/3/176 [pii]
    • (2005) Oncologist , vol.10 , pp. 176-182
    • Kaminskas, E.1    Farrell, A.T.2    Wang, Y.C.3    Sridhara, R.4    Pazdur, R.5
  • 84
    • 77956901498 scopus 로고    scopus 로고
    • The promise of microRNA replacement therapy
    • A.G. Bader, D. Brown, and M. Winkler The promise of microRNA replacement therapy Cancer Res 70 2010 7027 7030 10.1158/0008-5472.CAN-10-2010
    • (2010) Cancer Res , vol.70 , pp. 7027-7030
    • Bader, A.G.1    Brown, D.2    Winkler, M.3
  • 85
    • 84884815937 scopus 로고    scopus 로고
    • MicroRNAs as pharmacological targets in cancer
    • A. Soriano, L. Jubierre, and A. Almazan-Moga microRNAs as pharmacological targets in cancer Pharmacol Res 75 2013 3 14 10.1016/j.phrs.2013.03.006
    • (2013) Pharmacol Res , vol.75 , pp. 3-14
    • Soriano, A.1    Jubierre, L.2    Almazan-Moga, A.3
  • 86
    • 84887101163 scopus 로고    scopus 로고
    • MicroRNAs and other non-coding RNAs as targets for anticancer drug development
    • H. Ling, M. Fabbri, and G.A. Calin MicroRNAs and other non-coding RNAs as targets for anticancer drug development Nat Rev Drug Discov 12 2013 847 865 10.1038/nrd4140
    • (2013) Nat Rev Drug Discov , vol.12 , pp. 847-865
    • Ling, H.1    Fabbri, M.2    Calin, G.A.3
  • 87
    • 77949658280 scopus 로고    scopus 로고
    • Regression of murine lung tumors by the let-7 microRNA
    • P. Trang, P.P. Medina, and J.F. Wiggins Regression of murine lung tumors by the let-7 microRNA Oncogene 29 2010 1580 1587 10.1038/onc.2009.445
    • (2010) Oncogene , vol.29 , pp. 1580-1587
    • Trang, P.1    Medina, P.P.2    Wiggins, J.F.3
  • 88
    • 41649114199 scopus 로고    scopus 로고
    • Suppression of non-small cell lung tumor development by the let-7 microRNA family
    • M.S. Kumar, S.J. Erkeland, and R.E. Pester Suppression of non-small cell lung tumor development by the let-7 microRNA family Proc Natl Acad Sci U S A 105 2008 3903 3908 10.1073/pnas.0712321105
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 3903-3908
    • Kumar, M.S.1    Erkeland, S.J.2    Pester, R.E.3
  • 89
    • 42049103216 scopus 로고    scopus 로고
    • The let-7 microRNA reduces tumor growth in mouse models of lung cancer
    • 5834 [pii]
    • A. Esquela-Kerscher, P. Trang, and J.F. Wiggins The let-7 microRNA reduces tumor growth in mouse models of lung cancer Cell Cycle 7 2008 759 764 doi:5834 [pii]
    • (2008) Cell Cycle , vol.7 , pp. 759-764
    • Esquela-Kerscher, A.1    Trang, P.2    Wiggins, J.F.3
  • 90
    • 79957900919 scopus 로고    scopus 로고
    • Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice
    • P. Trang, J.F. Wiggins, and C.L. Daige Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice Mol Ther 19 2011 1116 1122 10.1038/mt.2011.48
    • (2011) Mol Ther , vol.19 , pp. 1116-1122
    • Trang, P.1    Wiggins, J.F.2    Daige, C.L.3
  • 91
    • 77956269093 scopus 로고    scopus 로고
    • Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy
    • Y. Chen, X. Zhu, X. Zhang, B. Liu, and L. Huang Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy Mol Ther 18 2010 1650 1656 10.1038/mt.2010.136
    • (2010) Mol Ther , vol.18 , pp. 1650-1656
    • Chen, Y.1    Zhu, X.2    Zhang, X.3    Liu, B.4    Huang, L.5
  • 92
    • 77955022405 scopus 로고    scopus 로고
    • Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34
    • J.F. Wiggins, L. Ruffino, and K. Kelnar Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 Cancer Res 70 2010 5923 5930 10.1158/0008-5472.CAN-10-0655
    • (2010) Cancer Res , vol.70 , pp. 5923-5930
    • Wiggins, J.F.1    Ruffino, L.2    Kelnar, K.3
  • 93
    • 84869083907 scopus 로고    scopus 로고
    • Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
    • V.J. Craig, A. Tzankov, M. Flori, C.A. Schmid, A.G. Bader, and A. Muller Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo Leukemia 26 2012 2421 2424 10.1038/leu.2012.110
    • (2012) Leukemia , vol.26 , pp. 2421-2424
    • Craig, V.J.1    Tzankov, A.2    Flori, M.3    Schmid, C.A.4    Bader, A.G.5    Muller, A.6
  • 94
    • 84869219338 scopus 로고    scopus 로고
    • MiR-34 - A microRNA replacement therapy is headed to the clinic
    • A.G. Bader miR-34-a microRNA replacement therapy is headed to the clinic Front Genet 3 2012 120 10.3389/fgene.2012.00120
    • (2012) Front Genet , vol.3 , pp. 120
    • Bader, A.G.1
  • 96
    • 28444469246 scopus 로고    scopus 로고
    • Silencing of microRNAs in vivo with 'antagomirs'
    • nature04303 [pii]
    • J. Krutzfeldt, N. Rajewsky, and R. Braich Silencing of microRNAs in vivo with 'antagomirs' Nature 438 2005 685 689 doi:nature04303 [pii]
    • (2005) Nature , vol.438 , pp. 685-689
    • Krutzfeldt, J.1    Rajewsky, N.2    Braich, R.3
  • 97
    • 83255194160 scopus 로고    scopus 로고
    • Chemical modification and design of anti-miRNA oligonucleotides
    • K.A. Lennox, and M.A. Behlke Chemical modification and design of anti-miRNA oligonucleotides Gene Ther 18 2011 1111 1120 10.1038/gt.2011.100
    • (2011) Gene Ther , vol.18 , pp. 1111-1120
    • Lennox, K.A.1    Behlke, M.A.2
  • 98
    • 84884252518 scopus 로고    scopus 로고
    • Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier
    • K.A. Lennox, R. Owczarzy, D.M. Thomas, J.A. Walder, and M.A. Behlke Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier Mol Ther Nucleic Acids 2 2013 e117 10.1038/mtna.2013.46
    • (2013) Mol Ther Nucleic Acids , vol.2 , pp. e117
    • Lennox, K.A.1    Owczarzy, R.2    Thomas, D.M.3    Walder, J.A.4    Behlke, M.A.5
  • 99
    • 33646027887 scopus 로고    scopus 로고
    • LNA-modified oligonucleotides mediate specific inhibition of microRNA function
    • S0378-1119(06)00023-0[pii]
    • U.A. Orom, S. Kauppinen, and A.H. Lund LNA-modified oligonucleotides mediate specific inhibition of microRNA function Gene 372 2006 137 141 doi:S0378-1119(06)00023-0[pii]
    • (2006) Gene , vol.372 , pp. 137-141
    • Orom, U.A.1    Kauppinen, S.2    Lund, A.H.3
  • 100
    • 34548316982 scopus 로고    scopus 로고
    • MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells
    • nmeth1079 [pii]
    • M.S. Ebert, J.R. Neilson, and P.A. Sharp MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Nat Methods 4 2007 721 726 doi:nmeth1079 [pii]
    • (2007) Nat Methods , vol.4 , pp. 721-726
    • Ebert, M.S.1    Neilson, J.R.2    Sharp, P.A.3
  • 102
    • 84877258007 scopus 로고    scopus 로고
    • Treatment of HCV infection by targeting microRNA
    • H.L. Janssen, H.W. Reesink, and E.J. Lawitz Treatment of HCV infection by targeting microRNA N Engl J Med 368 2013 1685 1694 10.1056/NEJMoa1209026
    • (2013) N Engl J Med , vol.368 , pp. 1685-1694
    • Janssen, H.L.1    Reesink, H.W.2    Lawitz, E.J.3
  • 103
    • 74249112787 scopus 로고    scopus 로고
    • Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
    • R.E. Lanford, E.S. Hildebrandt-Eriksen, and A. Petri Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 2010 198 201 10.1126/science.1178178
    • (2010) Science , vol.327 , pp. 198-201
    • Lanford, R.E.1    Hildebrandt-Eriksen, E.S.2    Petri, A.3
  • 104
    • 84881670319 scopus 로고    scopus 로고
    • Clinical evaluation of microRNA expression profiling in non small cell lung cancer
    • A. Markou, I. Sourvinou, P.A. Vorkas, G.M. Yousef, and E. Lianidou Clinical evaluation of microRNA expression profiling in non small cell lung cancer Lung Cancer 81 2013 388 396 10.1016/j.lungcan.2013.05.007
    • (2013) Lung Cancer , vol.81 , pp. 388-396
    • Markou, A.1    Sourvinou, I.2    Vorkas, P.A.3    Yousef, G.M.4    Lianidou, E.5
  • 105
    • 84878757129 scopus 로고    scopus 로고
    • Plasma processing conditions substantially influence circulating microRNA biomarker levels
    • H.H. Cheng, H.S. Yi, and Y. Kim Plasma processing conditions substantially influence circulating microRNA biomarker levels PLoS One 8 2013 e64795 10.1371/journal.pone.0064795
    • (2013) PLoS One , vol.8 , pp. e64795
    • Cheng, H.H.1    Yi, H.S.2    Kim, Y.3
  • 106
    • 79953301730 scopus 로고    scopus 로고
    • MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
    • K.C. Vickers, B.T. Palmisano, B.M. Shoucri, R.D. Shamburek, and A.T. Remaley MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat Cell Biol 13 2011 423 433 10.1038/ncb2210
    • (2011) Nat Cell Biol , vol.13 , pp. 423-433
    • Vickers, K.C.1    Palmisano, B.T.2    Shoucri, B.M.3    Shamburek, R.D.4    Remaley, A.T.5
  • 107
    • 34249302620 scopus 로고    scopus 로고
    • Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
    • ncb1596 [pii]
    • H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 2007 654 659 doi:ncb1596 [pii]
    • (2007) Nat Cell Biol , vol.9 , pp. 654-659
    • Valadi, H.1    Ekstrom, K.2    Bossios, A.3    Sjostrand, M.4    Lee, J.J.5    Lotvall, J.O.6
  • 108
    • 79953202200 scopus 로고    scopus 로고
    • Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
    • J.D. Arroyo, J.R. Chevillet, and E.M. Kroh Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Proc Natl Acad Sci U S A 108 2011 5003 5008 10.1073/pnas.1019055108
    • (2011) Proc Natl Acad Sci U S A , vol.108 , pp. 5003-5008
    • Arroyo, J.D.1    Chevillet, J.R.2    Kroh, E.M.3
  • 109
    • 85016304525 scopus 로고    scopus 로고
    • Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood
    • 10.3402/jev.v3.23743.eCollection 2014
    • L. Cheng, R.A. Sharples, B.J. Scicluna, and A.F. Hill Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood J Extracell Vesicles 3 2014 10.3402/jev.v3.23743 10.3402/jev.v3.23743.eCollection 2014
    • (2014) J Extracell Vesicles , vol.3
    • Cheng, L.1    Sharples, R.A.2    Scicluna, B.J.3    Hill, A.F.4
  • 110
    • 57049103401 scopus 로고    scopus 로고
    • Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
    • J. Skog, T. Wurdinger, and S. van Rijn Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat Cell Biol 10 2008 1470 1476 10.1038/ncb1800
    • (2008) Nat Cell Biol , vol.10 , pp. 1470-1476
    • Skog, J.1    Wurdinger, T.2    Van Rijn, S.3
  • 112
    • 79960960417 scopus 로고    scopus 로고
    • Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche
    • C. Grange, M. Tapparo, and F. Collino Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche Cancer Res 71 2011 5346 5356 10.1158/0008-5472.CAN-11-0241
    • (2011) Cancer Res , vol.71 , pp. 5346-5356
    • Grange, C.1    Tapparo, M.2    Collino, F.3
  • 113
    • 84904393091 scopus 로고    scopus 로고
    • Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer
    • M. Rodriguez, J. Silva, and A. Lopez-Alfonso Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer Genes Chromosom Cancer 53 2014 713 724 10.1002/gcc.22181
    • (2014) Genes Chromosom Cancer , vol.53 , pp. 713-724
    • Rodriguez, M.1    Silva, J.2    Lopez-Alfonso, A.3
  • 114
    • 84892702249 scopus 로고    scopus 로고
    • Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis
    • T. Yamashita, H. Kamada, and S. Kanasaki Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis Pharmazie 68 2013 969 973
    • (2013) Pharmazie , vol.68 , pp. 969-973
    • Yamashita, T.1    Kamada, H.2    Kanasaki, S.3
  • 115
    • 33746548361 scopus 로고    scopus 로고
    • Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes
    • 26/514 [pii]
    • S. Hao, Z. Ye, and F. Li Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes Exp Oncol 28 2006 126 131 doi:26/514 [pii]
    • (2006) Exp Oncol , vol.28 , pp. 126-131
    • Hao, S.1    Ye, Z.2    Li, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.